Clinical Trials

Oncology Services

Executive Health Program

Clinical Trials

Currently Open Protocols

Research Studies to be Offered Soon

Appointments

Financial Counseling

Services for International Patients

About Tan Tock Seng Hospital

About Our Staff

Directions and Transportation


	Mission, Vision and Core Values

	About Johns Hopkins in Singapore

	About Johns Hopkins Medicine

	About Singapore

	Latest News from Johns Hopkins Medicine

	Career Opportunities

Home

Home :: Patient Care :: Clinical Trials

Clinical Trials

Patients at Johns Hopkins Singapore International Medical Centre can elect to participate in clinical trials designed to find more effective therapies for cancer.

The Johns Hopkins tradition of innovation and discovery extends to patients at Johns Hopkins Singapore International Medical Centre who elect to participate in research studies called clinical trials. The aim is to find new therapies or more effective ways of using known treatments. Clinical and translational research is currently being conducted on new agents and innovative therapies on the following diseases: Breast cancer, lung cancer, nasopharyngeal cancer, and hepatocellular cancer.

Johns Hopkins Singapore International Medical Centre is part of the Cancer Therapeutics Research Group (CTRG). The CTRG is a research collaboration between the National University Hospital (NUH), National University of Singapore (NUS), Sydney Cancer Centre / University of Sydney, Johns Hopkins Singapore International Medical Centre, Chinese University of Hong Kong and National Cancer Centre, Singapore to engage the expertise of these institutions in developing novel therapy for cancer through clinical trials.

Please click here for more information on Clinical Trials.

If you wish to know more about our clinical trials, please email us at trial@imc.jhmi.edu.